Immediate Impact

1 by Nobel laureates 56 standout
Sub-graph 1 of 22

Citing Papers

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Physiology and pathophysiology of human airway mucus
2022 Standout
4 intermediate papers

Works of Adelaida Ferrer being referenced

Inhaled Tobramycin in Non—Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection with Pseudomonas Aeruginosa
2004

Author Peers

Author Last Decade Papers Cites
Adelaida Ferrer 286 352 45 141 13 649
Kathleen Jakob 82 131 79 283 15 617
Elizabeth Garber 172 182 34 165 20 542
Keisuke Naito 308 218 68 106 29 677
Philip A. Mackowiak 76 245 102 135 22 587
S.P. Conway 266 131 27 81 27 613
Anne Casetta 158 108 66 89 24 526
Michael B. Kirkpatrick 313 249 27 52 20 586
John McCracken 119 390 12 50 12 568
A Equi 414 173 29 41 7 533
C.H. Webb 175 284 18 235 18 629

All Works

Loading papers...

Rankless by CCL
2026